BioSyntech, Inc.
BSYI · OTC
3/31/2009 | 3/31/2008 | 3/31/2007 | 3/31/2006 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.04 | -0.24 | 0.12 | -0.13 |
| FCF Yield | -64.93% | -34.75% | -16.59% | -33.65% |
| EV / EBITDA | -2.20 | -2.82 | -5.92 | -2.91 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Margin | 60.82% | 62.81% | 63.09% | 65.20% |
| Cash Conversion Ratio | 0.74 | 0.90 | 0.93 | 0.90 |
| Growth | ||||
| Revenue 3-Year CAGR | -44.88% | 64.53% | 11.01% | -36.27% |
| Free Cash Flow Growth | -15.29% | -9.47% | -20.78% | -63.77% |
| Safety | ||||
| Net Debt / EBITDA | -0.78 | -0.03 | 0.02 | 0.38 |
| Interest Coverage | -43.09 | -24.16 | 0.00 | -10.49 |
| Efficiency | ||||
| Inventory Turnover | 0.28 | 5.06 | 32.59 | 6.48 |
| Cash Conversion Cycle | -516.02 | -2,058.77 | -231.13 | -18,573.54 |